Sensory Boxes include items such as drawing boards and fidget balls to support management of anxiety and improve shopping experience
The centre is equipped with the most modern tools and provides an environment soothing for all professionals and patients
Lenire is the first and only bimodal neuromodulation device to be awarded a Federal Supply Schedule (FSS) Contract from the US Government
Advancing IGC-AD1 Toward Commercialization as a Treatment for Agitation in Alzheimer's
Breakthrough Therapy designation for pain associated with DPN granted by FDA
First and only long-acting C5 complement inhibitor offers patients with AQP4 Ab+
AbCellera will receive an upfront payment and is eligible to receive additional milestone payments
The acquisition of Healint aligns with Aptar Digital Health’s strategy to broaden its portfolio in neurology and strengthen its global footprint for digital health deployment
Base4's drug discovery platform allows its collaborators to evaluate billions of novel small molecules to identify and progress RNA-modulators for important diseases
US FDA approval based on NEURO-TTRansform Phase III results
Subscribe To Our Newsletter & Stay Updated
